Search Results - "BURN, D. J"

EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease by Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., Ferreira, J., Gasser, T., Grandas, F., Kanovsky, P., Kostic, V., Kulisevsky, J., Oertel, W., Poewe, W., Reese, J.-P., Relja, M., Ruzicka, E., Schrag, A., Seppi, K., Taba, P., Vidailhet, M.

“…Background A Task Force was convened by the EFNS/MDS‐ES Scientist Panel on Parkinson's disease (PD) and other movement disorders to systemically review…”
Get full text

Prevalence and duration of non‐motor symptoms in prodromal Parkinson's disease by Durcan, R., Wiblin, L., Lawson, R. A., Khoo, T. K., Yarnall, A. J., Duncan, G. W., Brooks, D. J., Pavese, N., Burn, D. J.

“…Background and purpose The prevalence and duration of non‐motor symptoms (NMS) in prodromal Parkinson's disease (PD) has not been extensively studied. The aim…”
Get full text

Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study by Firbank, M J, Yarnall, A J, Lawson, R A, Duncan, G W, Khoo, T K, Petrides, G S, O'Brien, J T, Barker, R A, Maxwell, R J, Brooks, D J, Burn, D J

“…ObjectiveTo assess reductions of cerebral glucose metabolism in Parkinson's disease (PD) with 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET),…”
Get full text

Swallowing problems in Parkinson disease: frequency and clinical correlates by Miller, N, Allcock, L, Hildreth, A J, Jones, D, Noble, E, Burn, D J

“…Background:Changes to the efficiency and integrity of swallowing mechanisms are inevitable in Parkinson disease (PD); however, it remains unclear how many…”
Get full text

Cognitive impairment in Parkinson's disease: impact on quality of life of carers by Lawson, RA, Yarnall, AJ, Johnston, F, Duncan, GW, Khoo, TK, Collerton, D, Taylor, JP, Burn, DJ

“…Background The quality of life (QoL) of informal caregivers of people with Parkinson's disease (PD) (PwP) can be affected by the caring role. Because of…”
Get full text

Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies by Burn, D J, Rowan, E N, Allan, L M, Molloy, S, O’Brien, J T, McKeith, I G

“…Background: A previous cross sectional study found over-representation of a postural instability gait difficulty (PIGD) motor subtype in Parkinson’s disease…”
Get full text

Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis by Landau, S, Harris, V, Burn, D J, Hindle, J V, Hurt, C S, Samuel, M, Wilson, K C, Brown, R G

“…Depression and anxiety in Parkinson's disease are common and frequently co-morbid, with significant impact on health outcome. Nevertheless, management is…”
Get more information

Visual perception in Parkinson disease dementia and dementia with Lewy bodies by MOSIMANN, U. P, MATHER, G, WESNES, K. A, O'BRIEN, J. T, BURN, D. J, MCKEITH, I. G

“…To quantify visual discrimination, space-motion, and object-form perception in patients with Parkinson disease dementia (PDD), dementia with Lewy bodies (DLB),…”
Get full text

Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study by Gibson, G., Mottram, P. G., Burn, D. J., Hindle, J. V., Landau, S., Samuel, M., Hurt, C. S., Brown, R. G., M Wilson, K. C.

“…Objective To examine the prevalence, incidence and risk factors associated with visual hallucinations (VHs) amongst people suffering from Parkinson's disease…”
Get full text

Temporal lobe atrophy on MRI in Parkinson disease with dementia : A comparison with Alzheimer disease and dementia with Lewy bodies by TAM, C. W. C, BURTON, E. J, MCKEITH, I. G, BURN, D. J, O'BRIEN, J. T

“…To investigate the extent of medial temporal lobe atrophy (MTA) on MRI in Parkinson disease (PD) with and without dementia compared with Alzheimer disease (AD)…”
Get full text

Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study by NATH, U, BEN-SHLOMO, Y, THOMSON, R. G, LEES, A. J, BURN, D. J

“…To describe clinical features and identify prognostic predictors in progressive supranuclear palsy (PSP). Record-based diagnosis according to National…”
Get full text

Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson’s disease by Allcock, L M, Ullyart, K, Kenny, R A, Burn, D J

“…The frequency of orthostatic hypotension (OH) in cohorts of patients recruited through hospital Parkinson’s disease (PD) clinics ranges from 16% to 58%…”
Get full text

Effect of levodopa on cognitive function in Parkinson’s disease with and without dementia and dementia with Lewy bodies by Molloy, S A, Rowan, E N, O’Brien, J T, McKeith, I G, Wesnes, K, Burn, D J

“…Background: Levodopa (L-dopa) is the gold standard treatment for Parkinson’s disease, but a lack of clear efficacy combined with a perceived liability to…”
Get full text

Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson's Disease Cohort (ICICLE-PD) by Dlay, J K, Duncan, G W, Khoo, T K, Williams-Gray, C H, Breen, D P, Barker, R A, Burn, D J, Lawson, R A, Yarnall, A J

“…Cross-sectional studies have identified that the prevalence of neuropsychiatric symptoms (NPS) in Parkinson's disease (PD) ranges from 70-89%. However, there…”
Get full text

Neurology and the kidney by Burn, D J, Bates, D

“…Renal failure is relatively common, but except in association with spina bifida or paraplegia it is unlikely to occur as a result of disease of the CNS. Renal…”
Get full text

The prevalence of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) in the UK by Nath, U., Ben-Shlomo, Y., Thomson, R. G., Morris, H. R., Wood, N. W., Lees, A. J., Burn, D. J.

“…We performed a study to estimate the point prevalence of progressive supranuclear palsy (PSP) in the UK at national, regional and community levels. A `Russian…”
Get full text

Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease by CAIRNS, N. J, GROSSMAN, M, CRUZ-SANCHEZ, F. F, BIGIO, E. H, MACKENZIE, I. R. A, GEARING, M, JUNCOS, J. L, GLASS, J. D, YOKOO, H, NAKAZATO, Y, MOSAHEB, S, THORPE, J. R, ARNOLD, S. E, URYU, K, LEE, V. M.-Y, TROJANOWSKI, J. Q, BURN, D. J, JAROS, E, PERRY, R. H, DUYCKAERTS, C, STANKOFF, B, PILLON, B, SKULLERUD, K

“…Recently described neuronal intermediate filament inclusion disease (NIFID) shows considerable clinical heterogeneity. To assess the spectrum of the clinical…”
Get full text

Depression in Parkinson's disease by Burn, D. J.

“…Depression in Parkinson's disease (PD) is a common complication, with a major impact on quality of life. Failure to recognize and treat depression can lead to…”
Get full text

Cholinergic systems in progressive supranuclear palsy by Warren, N. M., Piggott, M. A., Perry, E. K., Burn, D. J.

“…Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disease characterized by akinetic-rigid features, falls, a supranuclear gaze palsy and…”
Get full text

The role of levodopa in the management of dementia with Lewy bodies by Molloy, S, McKeith, I G, O’Brien, J T, Burn, D J

“…Background: One of the core clinical features of dementia with Lewy bodies (DLB) is extrapyramidal syndrome (EPS). Levodopa is currently the gold standard oral…”
Get full text